Tag Archive | "pharma deals"

Cepheid signs pharma deal with 3 big pharmas

Tags: , ,


Cepheid announced a new pharma deal with AstraZeneca, Cubist Pharmaceuticals, and GSK intended to promote transformational change in infectious disease therapy. Read the full story

Pfizer signs a pharma deal with Cellectis

Tags: , , ,


Pfizer have entered into a pharma deal collaboration with Cellectis to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets. Read the full story

Pfizer has signed a biotech deal with Sepha

Tags: , ,


Sepha has clinched a $1.5M export contract with the world's largest pharmaceutical company, Pfizer, to supply its proprietary technology, VisionScan, for the non-destructive seal and leak detection of Pfizer's blister packs. Read the full story

NanoString signs a pharma deal with Celegene

Tags: , ,


NanoString Technologies entered into a pharma deal with Celgene to develop a companion diagnostic assay using the nCounter Analysis System to support the clinical validation of REVLIMID for treatment of Diffuse Large B-Cell Lymphoma for $45 million. Read the full story

Antibody: recent life science partnering trends

Tags: , , ,


Antibodies are the subject of numerous partnering deals every year, here we provide a review of recent partnering trends activity. Read the full story

Aduro signs a pharma deal with Janssen Biotech

Tags: , , ,


Aduro BioTech has entered into an pharma deal granting Janssen Biotech an exclusive, worldwide license to certain product candidates specifically engineered for the treatment of prostate cancer based on its novel LADD immunotherapy platform. Read the full story

MarcoGenics and Takeda sign a pharma deal for autoimmune diseases

Tags: , , ,


MacroGenics and Takeda Pharmaceutical have entered into an option agreement for pharma deal for the development and commercialization of MGD010. Read the full story

Neurotez signs licensing deal for Leptin

Tags: , ,


Neurotez announced the execution of an exclusive license agreement covering its Leptin derivatives (Leptin Products), for the treatment of Alzheimer’s disease (AD) and other cognitive disorders, with GCA Therapeutics. Read the full story

Novartis enters into licensing deal with Ophthotech

Tags: , , ,


Novartis has acquired from Ophthotech exclusive rights to market the eye drug candidate Fovista outside the U.S., while retaining U.S. marketing rights, under a licensing deal and commercialization agreement that could net Opthotech more than $1 billion. Read the full story

Pfizer enters into research deal with BioRestorative

Tags: , ,


BioRestorative Therapies announced that it has entered into a two-year collaborative Research Agreement with Pfizer to study human brown adipose tissue and cell lines. Read the full story